2020 | 2021 | Jan.−July 2022 | |
---|---|---|---|
First cancer appointment | -1.8 (-4.4; 0.9) | 5.4 (2.6; 8.2) | 29.0 (25.0; 33.1) |
Follow-up cancer appointment | -2.8 (-3.8; -1.9) | -14.3 (-15.2; -13.3) | -28.5 (-29.6; -27.4) |
Oncological genetic testing and counselling | -11.9 (-16.3; -7.3) | 15.3 (10.2; 20.5) | 27.0 (20.1; 34.3) |
Radiotherapy | 5.7 (2.7; 8.8) | 12.6 (9.4; 15.8) | 13.8 (9.7; 18.1) |
Surgery | -10.9 (-13.5; -8.3) | 5.8 (3.0; 8.7) | 15.7 (11.8; 19.6) |
Medical oncology | -2.0 (-5.7; 1.8) | 2.4 (-1.4; 6.3) | 10.9 (5.7; 16.4) |
All | -3.1 (-4.8; -1.3) | 8.7 (6.9; 10.6) | 15.3 (12.8; 17.8) |
Radiotherapy | -13.6 (-14.6; -12.6) | -2.6 (-3.7; -1.6) | -2.1 (-3.5; -0.8) |
Surgery | -13.2 (-14.3; -12.1) | -4.7 (-5.9; -3.5) | -8.1 (-9.6; -6.6) |
Medical oncology | 2.3 (1.3; 3.3) | 12.8 (11.8; 13.9) | 18.4 (17.0; 19.9) |
All | -6.9 (-7.5; -6.3) | 7.0 (6.3; 7.6) | 8.1 (7.3; 9.0) |
X-ray | -8.4 (-10.3; -6.4) | -0.5 (-2.5; 1.5) | -2.2 (-4.8; 0.5) |
Mammography | 2.8 (0.8; 4.8) | 7.7 (5.7; 9.7) | 8.2 (5.5; 10.8) |
Ultrasound scans | -4.5 (-6.2; -2.8) | 9.6 (7.8; 11.4) | 19.6 (17.1; 22.1) |
CT imaging | 22.8 (20.8; 24.9) | 45.7 (43.6; 47.9) | 70.1 (67.0; 73.3) |
MRI | 14.8 (11.5; 18.1) | 35.9 (32.4; 39.6) | 38.5 (33.8; 43.3) |
PET | 4.6 (0.5; 8.8) | 8.9 (4.8; 13.2) | 11.7 (6.2; 17.4) |
Average 2015−2019 (95% CI) | N for 2020 | Change (%) in 2020 against average (95% CI) | N for 2021 | Change (%) in 2021 against average (95% CI) | ||
---|---|---|---|---|---|---|
6635.4 | (6458.9 ; 6811.9) | 6217 | -6.3 (-8.6 ; -3.9) | 6064 | -8.6 (-10.9 ; -6.3) | |
Males | 3334.0 | (3219.4 ; 3448.6) | 3157 | -5.3 (-8.6 ; -1.9) | 2978 | -10.7 (-13.9 ; -7.4) |
Females | 3301.4 | (3218.9 ; 3383.9) | 3060 | -7.3 (-10.6 ; -4.0) | 3086 | -6.5 (-9.8 ; -3.2) |
20-49 | 939.6 | (911.9 ; 967.3) | 935 | -0.5 (-6.8 ; 6.1) | 901 | -4.1 (-10.3 ; 2.4) |
50-64 | 2287.6 | (2189.2 ; 2386.0) | 1958 | -14.4 (-18.2 ; -10.5) | 1912 | -16.4 (-20.1 ; -12.6) |
65-79 | 2651.6 | (2534.0 ; 2769.2) | 2546 | -4.0 (-7.7 ; -0.2) | 2493 | -6.0 (-9.6 ; -2.2) |
80+ | 695.4 | (676.2 ; 714.6) | 721 | 3.7 (-3.7 ; 11.5) | 750 | 7.9 (0.3 ; 15.9) |
Primary diagnostics | 904.4 | (858.9 ; 949.9) | 884 | -2.3 (-8.6 ; 4.4) | 777 | -14.1 (-20 ; -7.8) |
Primary treatment | 4791.2 | (4664.9 ; 4917.5) | 4493 | -6.2 (-8.9 ; -3.4) | 4358 | -9.0 (-11.7 ; -6.3) |
Diagnostics or | ||||||
treatment for | 874.8 | (824.9 ; 924.7) | 779 | -11.0 (-17.1 ; -4.5) | 838 | -4.2 (-10.6 ; 2.5) |
relapse | ||||||
Other or unknown | 65.0 | (43.5 ; 86.5) | 61 | -6.2 (-28.2 ; 20.5) | 91 | 40.0 (12.7 ; 71.9) |
Localized | 2029.2 | (1956.8 ; 2101.6) | 1943 | -4.2 (-8.5 ; 0.1) | 1843 | -9.2 (-13.3 ; -4.9) |
Regional | 2061.0 | (2026.1 ; 2095.9) | 1879 | -8.8 (-12.9 ; -4.6) | 1723 | -16.4 (-20.3 ; -12.4) |
Distant | 1093.4 | (1018.3 ; 1168.5) | 1010 | -7.6 (-13.2 ; -1.8) | 1009 | -7.7 (-13.3 ; -1.8) |
Unknown | 41.6 | (36.4 ; 46.8) | 56 | 34.6 (1.7 ; 74.8) | 92 | 121.2 (78.3 ; 171.2) |
Not applicable | 470.4 | (430.7 ; 510.1) | 489 | 4.0 (-5.1 ; 13.6) | 468 | -0.5 (-9.3 ; 8.9) |